US Patent Issued to Bristol-Myers Squibb on June 30 for "MK2 inhibitors and uses thereof" (Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,598, issued on June 30, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"MK2 inhibitors and uses thereof" was invented by Xirui Hu (Cambridge, Mass.), Lixin Qiao (Andover, Mass.), Boris Seletsky (Cambridge, Mass.), Matthew Patton (Cambridge, Mass.), Min Cao (Cambridge, Mass.), Farid van der Mei (Summit, N.J.), Guobin Miao (Lexington, Mass.), Ivar McDonald (Cambridge, Mass.) and Carolyn Dzierba (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds, compositions thereof, and methods of using the MK2 inhibitors of the Formula:"

The patent was filed on Oct. 26, 2023, under Application No. ...